One reform that Malvinder couldn't do was that of the company's board of directors. For long, doctors and scientists have been inadequately represented on the Ranbaxy board. The new owner will have to address this problem.
"We are just watching Amar Singh. We don't want to fall into his trap. He is not a 24-hour political worker and wants the ladder of the Rajya Sabha seat till alternative arrangements are made," party general secretary Mohan Singh told PTI.
Sources say the firm had to act to calm Japanese investors, restive at the flow of bad news.
Hospital chain Fortis Healthcare's Rs 1,000 crore (Rs 10 billion) rights issue is likely to hit the market by October, with the firm taking fresh steps to realise the plan.
Bihar being in the grip of a Dusshera festival mood, leaders of rival political groups including Rashtriya Janata Dal supremo Lalu Prasad Yadav on Tuesday used examples of slaying of Ravana to attack each other.
For the first time, Subramanian said, "the Economic Survey has embraced Big Data, and we mine this data to shed new light on the flow of goods and people within India."
Pharmaceuticals major Ranbaxy Laboratories plans to leverage the cost advantage of Chinese raw materials by making China its major active pharmaceutical ingredient sourcing hub.
Commenting on the closure of the deal, Ranbaxy CEO Malvinder Mohan Singh said, "The deal has been closed successfully. This puts us well on the path to creating a hybrid business model that will unlock the strengths of both companies to bring unprecedented value to all stakeholders." In June, Japanese firm Daiichi Sankyo had entered into an agreement to buy out the promoters' stake of 34.8 per cent and subsequently made open offer for a 20 per cent stake at Rs 737 per share.
With Samajwadi Party cosying up to the Congress, its leaders have been invited for the fourth UPA anniversary celebrations scheduled here on May 22. In a clear message that it was warming up to the Congress, SP supremo Mulayam Singh Yadav had recently lashed out at BSP leader Mayawati for being 'ungrateful' to the United Progressive Allaince government by criticising it. He added that Congress 'charity' had only helped her become the Chief Minister of Uttar Pradesh again.
"It will be the team I choose to have with the approval of the board. It is really our call on how to run the business. Certainly, the growth will be higher and so will be the size and scale of the investments. You will see a lot more aggression in terms of leveraging opportunities for the next few years," says Ranbaxy CEO Malvinder Mohan Singh.
Janata Dal-United president Sharad Yadav on Wednesday visited the native village of jailed criminal-turned-politician Anand Mohan Singh, a former MP serving life sentence in a murder case, to seek blessings of his mother for the Lok Sabha polls.
BJP, SP and CPI accuse Lalu's railway Budget as being discriminatory, parochial and disappointing.
A Delhi court on Friday convicted 17 Uttarakhand Police personnel, seven of them for murder and others for various offences including criminal conspiracy and kidnapping in a fake encounter case in which an MBA student was shot dead in Uttarakhand in 2009.
Singh said they will focus on Fortis Healthcare and Religare Financial Services after the acquisition.
Articulate segments of Muzaffarpur have been at the the forefront of all anti-establishment mobilisation, which makes their silence over the atrocities in a shelter home in the town puzzling. Could it be that if those accused of horrific crimes belong to dominant castes and if the victims belong to the vulnerable groups, then the middle classes become mute, asks Mohammad Sajjad.
Non-performers were not punished, performers were not rewarded, points out Utkarsh Mishra.
India's leading drug maker Ranbaxy Laboratories is likely to announce a drug discovery research tie-up with US drug manufacturer Merck soon. Ranbaxy's ongoing research collaboration with GSK also relates to the pre-clinical trial phase of the new drug, with significant milestone payment and post-commercialisation royalty possibilities. Ranbaxy's decision to de-merge its research operations was intended at having more collaborative research programmes involving foreign firms.
Singh, who took charge of EHIRC, relinquished the new position as part of new the settlement and would continue as the Managing Director of EHIRC
Government's objective is to bring down the cost of cultivation through efficient use of fertilisers and agro chemicals, and increase in realisation. It is, thus, planning to connect 200 agricultural mandis with electronic National Agricultural Mandis this year and 225 next year, to enable farmers to sell their produce hassle-free online.
Angered by the charges that it was behind the 'cash for votes' scam, Samajwadi Party on Wednesday said it will be moving a breach of privilege against the three Bharatiya Janata Party MPs who made the charge. SP leader Mohan Singh told reporters that he has informed Speaker Somnath Chatterjee that his party would be giving a privilege notice against the BJP MPs for tarnishing the image of Parliament.
All medicines that have USFDA approvals continue to be produced in the Poanta Sahib facility. The USFDA has not given any approval for new drugs as they have some concerns. We are addressing them, Malvinder Singh said.
Since Malvinder Mohan Singh announced last week that he would sell leading Indian generic drug maker Ranbaxy to Daiichi Sankyo of Japan, incredulous friends have deluged him with messages.
US giant expected to bid for 65% non-promoter stake.
Continuing with its push in the US market, Ranbaxy Laboratories said on Monday it has acquired the marketing rights for 13 skincare products from Bristol-Myers Squibb Company for $26 million.
The public prosecutor said the court found seven of the 38 accused guilty under Section 302 of the IPC.
The US Congressional Committee's move to probe approvals by the USFDA of the company's drug is a part of the larger game by an MNC -- 'trying to scuttle its deal with Daiichi Sankyo', Ranbaxy CEO Malvider Mohan Singh said in New Delhi. Recently, the department of justice has filed a motion in the US court against Ranbaxy alleging systematic fraudulent conduct and supplying fabricated information to the USFDA.
Security of Union Finance Minister Arun Jaitley has been upgraded to topmost Z-plus category and he will be guarded by paramilitary commandos drawn from Central Industrial Security Force now.
Ranbaxy, one of the first Indian companies to set up a venture in China in 1993, is bullish in its operations.
Ranbaxy has completed the second phase of the clinical trial of a revolutionary anti-malarial drug that could enable it to be the nation's first pharmaceutical company to launch a New Chemical Entity globally.
Promoter of Ranbaxy Laboratories, Malvinder Mohan Singh, not only sold a strategic stake in his company to Japanese pharma major Daiichi Sankyoand, he even managed to get a good increment for himself. According to the company's extraordinary general meeting notice, Singh will now earn a salary and allowances of Rs 25 crore per annum as against Rs 19.58 crore earlier.
The IAF 'evidence' shows that the S-2000 laser-guided munition hit the intended targets causing significant 'internal damage', sources said.
As many as 48 ministers of National Democratic Allaince government were in the fray in the general elections.
Ranbaxy earned $114 million from its US operations in 2006. It launched 10 new products during the year. The company said that the revenues from the sale of the newly acquired brands would be reflected from the next quarter.
Ranbaxy Laboratories, the country's biggest drugmaker, is all set to focus its energies in developing and marketing niche products where price erosion is minimal
A Muslim yoga expert will teach yoga to BJP president Amit Shah at a special yoga camp in Patna on June 21 to mark the International Yoga Day celebrations. M I Khan Reports.
In 2008, Daiichi Sankyo had bought the entire 34.82 per cent stake in Ranbaxy from its promoters, Malvinder Mohan Singh and family, for $4.2 billion. Currently, Singh is executive chairman of Fortis Healthcare.
The polling for the sixth phase on May 12 covers 6 states and one Union Territory.
A day after being sworn-in, the new ministers took charge of their portfolios. Here's a look at the various new ministers on their first day at work.
The army denied that two hard drives were stolen, as reported by some television channels.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances